Showing results (31-40 of 173) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid LeukemiaNa Shen, Fei Yan, Jiuxia Pang, et al.Journal of Clinical Medicine|June 2, 2021
Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic HematopathologyMazen Osman, Zeynettin Akkus, Dragan Jevremovic, et al.American Journal of Hematology|January 10, 2023
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expressionAref Al-Kali, Raoul Tibes, Pamela Atherton, et al.Haematologica|November 8, 2011
Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patientsAref Al-Kali, Sergej Konoplev, Erpei Lin, et al.Oncotarget|May 5, 2016
Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axisXiaojuan Yang, Jiuxia Pang, Na Shen, et al.Clinical Colorectal Cancer|September 17, 2008
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 casesMichael J Overman, David Fogelman, Aref Al-Kali, et al.Haematologica|March 20, 2025
Predictors of response to pacritinib therapy and survival among 60 Mayo Clinic patients with myelofibrosis treated outside of clinical trialsMaymona Abdelmagid, Jeanne M Palmer, Aref Al-Kali, et al.International Journal of Cancer|October 13, 2015
Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparisonBelal Firwana, Mohamad Bassam Sonbol, Maria Diab, et al.British Journal of Haematology|November 3, 2021
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive casesAyalew Tefferi, Jaya Kittur, Faiqa Farrukh, et al.American Journal of Hematology|September 29, 2023
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative casesAyalew Tefferi, Maymona Abdelmagid, Aref Al-Kali, et al.Pageof 18